Evome Medical Technologies Inc.

LNDZF · OTC
Analyze with AI
9/30/2024
6/30/2024
3/31/2024
12/31/2023
Operating Activities
Net Income-$1-$2-$4-$16
Dep. & Amort.$2$0$0-$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0-$0$0
Change in WC$2-$0$2$1
Other Non-Cash-$1$5$2$16
Operating Cash Flow$2$3-$1$1
Investing Activities
PP&E Inv.-$0$0-$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0$0-$0$0
Financing Activities
Debt Repay.-$2-$3-$0-$2
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow-$2-$3-$0-$2
Forex Effect$0$0$0$0
Net Chg. in Cash$0$1-$1-$0
Supplemental Information
Beg. Cash$1$0$1$1
End Cash$1$1$0$1
Free Cash Flow$2$3-$1$1